Leica
Biosystems announced that an affiliate has entered into a definitive agreement
to acquire Aperio, a provider of ePathology solutions.
Aperio
will be integrated into Leica Biosystems, a provider of anatomical pathology
solutions. Together, the two businesses will leverage each other’s strengths to
grow and expand digital pathology into the global life science and health care
markets. The integrated business will provide solutions in each step of the
anatomical pathology workflow, from sample preparation and staining, to imaging
and reporting. The company will continue to offer both the Aperio and the
existing Leica portfolio of Digital Pathology solutions, so that customers will
enjoy more freedom to choose a solution that meets their individual needs.
Aperio’s
ePathology Solutions include whole slide scanners, a Network solution that
enables remote, real-time viewing and easy distribution of images for peer
review, collaboration, and consultation. Its Precision solution provides
pathologists with easy-to-use quantitative image analysis to improve research
and clinical productivity, reproducibility, and consistency. Customers include
clinicians and researchers working in hospitals, reference laboratories,
pharmaceuticals, and research institutions.
Source: Leica Biosystems
